Your browser doesn't support javascript.
loading
Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center.
Galateau Salle, Francoise; Le Stang, Nolwenn; Tirode, Franck; Courtiol, Pierre; Nicholson, Andrew G; Tsao, Ming-Sound; Tazelaar, Henry D; Churg, Andrew; Dacic, Sanja; Roggli, Victor; Pissaloux, Daniel; Maussion, Charles; Moarii, Matahi; Beasley, Mary Beth; Begueret, Hugues; Chapel, David B; Copin, Marie Christine; Gibbs, Allen R; Klebe, Sonja; Lantuejoul, Sylvie; Nabeshima, Kazuki; Vignaud, Jean-Michel; Attanoos, Richard; Brcic, Luka; Capron, Frederique; Chirieac, Lucian R; Damiola, Francesca; Sequeiros, Ruth; Cazes, Aurélie; Damotte, Diane; Foulet, Armelle; Giusiano-Courcambeck, Sophie; Hiroshima, Kenzo; Hofman, Veronique; Husain, Aliya N; Kerr, Keith; Marchevsky, Alberto; Paindavoine, Severine; Picquenot, Jean Michel; Rouquette, Isabelle; Sagan, Christine; Sauter, Jennifer; Thivolet, Francoise; Brevet, Marie; Rouvier, Philippe; Travis, William D; Planchard, Gaetane; Weynand, Birgit; Clozel, Thomas; Wainrib, Gilles.
Affiliation
  • Galateau Salle F; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France. Electronic address: francoise.galateau@lyon.unicancer.fr.
  • Le Stang N; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France.
  • Tirode F; University Claude Bernard Lyon, INSERM, CNRS, Research Cancer Center of Lyon, Centre Léon Bérard, Lyon, France.
  • Courtiol P; OWKIN Paris, France.
  • Nicholson AG; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Tsao MS; University Health Network, Princess Margaret Cancer Centre and University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, Ontario, Canada.
  • Tazelaar HD; Mayo Clinic, Scottsdale, Arizona.
  • Churg A; Columbia University and Department of Pathology Vancouver, Canada.
  • Dacic S; FISH and Developmental Laboratory at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Roggli V; Duke University Medical Center, Department of Pathology, Durham, North Carolina.
  • Pissaloux D; Department of BioPathology-FISH Laboratory, Centre Leon Berard Lyon, France.
  • Maussion C; OWKIN Paris, France.
  • Moarii M; OWKIN Paris, France.
  • Beasley MB; Mount-Sinai Medical Center, Department of Pathology, New York, New York.
  • Begueret H; CHU Bordeaux, Haut Leveque Hospital, Department of Pathology, Bordeaux, France.
  • Chapel DB; University of Chicago, Department of Pathology, Chicago, Illinois.
  • Copin MC; University. Lille-CHU, Department of Pathology, Lille, France.
  • Gibbs AR; University of Wales, Department of Cellular Pathology, Cardiff, United Kingdom.
  • Klebe S; Department of Anatomical Pathology, Flinders University, Adelaide, Australia.
  • Lantuejoul S; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France.
  • Nabeshima K; Department of Pathology, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan.
  • Vignaud JM; CHU Nancy, INSERM, University of Lorraine, Lorraine, France.
  • Attanoos R; University of Wales, Department of Cellular Pathology, Cardiff, United Kingdom.
  • Brcic L; Department of Pathology, Graz, Austria.
  • Capron F; CHU Pitié Salpétrière Paris, Department of Pathology, Paris, France.
  • Chirieac LR; Brigham and Women's Hospital, Boston, Massachusetts.
  • Damiola F; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France.
  • Sequeiros R; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France.
  • Cazes A; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Bichat Department of Pathology, University Paris VII, Paris, France.
  • Damotte D; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Cochin-Hotel Dieu, Department of Pathology, Paris, France.
  • Foulet A; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CH Le Mans, Department of Pathology, Pays de la Loire, France.
  • Giusiano-Courcambeck S; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Hospital Nord, Marseille, University Aix-Marseille, Marseille, France.
  • Hiroshima K; Tokyo Women's Medical University, Department of Pathology, Tokyo, Japan.
  • Hofman V; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Mayo Clinic, Scottsdale, Arizona; CHU Nice, Department of Clinical and Experimental Pathology (LPCE), Nice, France.
  • Husain AN; University of Chicago, Department of Pathology, Chicago, Illinois.
  • Kerr K; Aberdeen Royal Infirmary, Department of Pathology, Aberdeen, Scotland.
  • Marchevsky A; Scotland Cedars-Sinai Medical Center, Department of Pathology, Los Angeles, California.
  • Paindavoine S; University Claude Bernard Lyon, INSERM, CNRS, Research Cancer Center of Lyon, Centre Léon Bérard, Lyon, France.
  • Picquenot JM; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Department of Pathology, Henri Becquerel Centre, Rouen, France.
  • Rouquette I; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; IUCT-Oncopôle, Department of Pathology, Toulouse, France.
  • Sagan C; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Nantes, INSERM, Thorax Institute, Hôpital Laënnec CHU Nantes, Nantes, France.
  • Sauter J; Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York.
  • Thivolet F; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Hospices Civils, East Hospital Group, Department of Pathology, Lyon, France.
  • Brevet M; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Hospices Civils, East Hospital Group, Department of Pathology, Lyon, France.
  • Rouvier P; CHU Pitié Salpétrière Paris, Department of Pathology, Paris, France.
  • Travis WD; Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York.
  • Planchard G; MESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; Department of Pathology, CHU Caen, Caen, France.
  • Weynand B; UZ Leuven, Department of Pathology, Leuven, Belgium.
  • Clozel T; OWKIN Paris, France.
  • Wainrib G; OWKIN Paris, France.
J Thorac Oncol ; 15(6): 1037-1053, 2020 06.
Article in En | MEDLINE | ID: mdl-32165206
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deep Learning / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials Limits: Humans Language: En Journal: J Thorac Oncol Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Deep Learning / Lung Neoplasms / Mesothelioma Type of study: Clinical_trials Limits: Humans Language: En Journal: J Thorac Oncol Year: 2020 Document type: Article Country of publication: